Christina Ferraro
Family · Cleveland, OHNPI 1881047306
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $12,985 of the $18,475 with a category attached, or 70.3%. Incyte Corporation accounts for 74.2% of it on its own, with 11 other manufacturers making up the rest. 2025 is the largest year on record at $9,810, 7.9 times the $1,241 reported in 2021. Among family clinicians in OH with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 39 payments — averaging $473.71 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Incyte Corporation$14K
- Sanofi-aventis U.S. LLC$3K
- Kadmon Pharmaceuticals LLC$952
- Astellas Pharma US Inc$399
- Johnson & Johnson$237
- AstraZeneca$191
- plus $447 from 6 others
What the payments were for
- Consulting fees$12,98570%
- Speaking & faculty fees$2,30712%
- Travel & lodging$8294%
- Food & beverage$1,3928%
- Education$9625%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Incyte Corporation | 18 | $13,708 |
| Sanofi-aventis U.S. LLC | 4 | $2,541 |
| Kadmon Pharmaceuticals LLC | 1 | $952 |
| Astellas Pharma US Inc | 5 | $399 |
| Johnson & Johnson | 2 | $237 |
| AstraZeneca(2 entities) | 2 | $191 |
| Lilly USA, LLC | 2 | $166 |
| Biolinerx USA, Inc. | 1 | $118 |
| Bayer | 1 | $75 |
| Merck | 1 | $49 |
| Novartis | 1 | $23 |
| Amgen | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$18,475 in reported general payments places this provider in the 95th percentile of 6,812 family providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dexamethasone | 14 | $1,135 |
| Acyclovir | 62 | $768 |
| Pantoprazole Sodium | 44 | $587 |
| Tacrolimus | 14 | $482 |
| Rosuvastatin Calcium | 45 | $464 |
| Potassium Chloride | 15 | $340 |
| Gabapentin | 14 | $208 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 23 | $53 |
| Fluconazole | 13 | $45 |
| Trazodone Hcl | 12 | $36 |
Paid to pharmacies, not to this prescriber.
Other family in Cleveland
- Tina CorkwellCleveland$55K
- Sophia WoodsonCleveland$53K
- Shannon ShafferCleveland$22K
- Leigh Ann PanschDayton$670K
- Natalie BelliniMayfield Heights$582K
- Kaitlyn LovettMontgomery$286K
- Amy RossDayton$281K
- Renee OttSandusky$179K
- Megan MillerSpringfield$156K
- George KnightCincinnati$130K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.